PRESSRELEASES
15 May, 2025
Bulletin from Nanexa’s Annual General Meeting
The Annual General Meeting (AGM) of Nanexa AB (publ) has been held on May 15, 2025, at which meeting submitted proposals were passed. The complete proposals for resolutions are set out in the AGM notice.
READ MORE6 May, 2025
Nanexa publishes interim report for January-March 2025
Very interesting data from the latest study and successful share issue.
READ MORELATEST REPORTS
PRESENTATIONS
16 June 2025
Intervju med vd David Westberg från The Pharma Navigator
6 May 2025
Q1 report commentary with CEO David Westberg
MEET NANEXA
20 - 23 Jun, 2025
American Diabetes Association (ADA) Scientific Sessions i Chicago, USA
Bolagets fas I-data för NEX-22 har accepterats som ett Late Breaking Abstract och kommer att presenteras som poster.
14 - 18 Jul, 2025
Controlled Release Society (CRS) Annual Meeting i Philadelphia, USA
Nanexa håller en entimmes muntlig presentation om PharmaShell®